287 related articles for article (PubMed ID: 23845326)
1. Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes.
Ardawi MS; Akhbar DH; Alshaikh A; Ahmed MM; Qari MH; Rouzi AA; Ali AY; Abdulrafee AA; Saeda MY
Bone; 2013 Oct; 56(2):355-62. PubMed ID: 23845326
[TBL] [Abstract][Full Text] [Related]
2. Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus.
Yamamoto M; Yamauchi M; Sugimoto T
J Clin Endocrinol Metab; 2013 Oct; 98(10):4030-7. PubMed ID: 23894157
[TBL] [Abstract][Full Text] [Related]
3. Serum insulin-like growth factor-I is a marker for assessing the severity of vertebral fractures in postmenopausal women with type 2 diabetes mellitus.
Kanazawa I; Yamaguchi T; Sugimoto T
Osteoporos Int; 2011 Apr; 22(4):1191-8. PubMed ID: 20532480
[TBL] [Abstract][Full Text] [Related]
4. Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus.
Gaudio A; Privitera F; Battaglia K; Torrisi V; Sidoti MH; Pulvirenti I; Canzonieri E; Tringali G; Fiore CE
J Clin Endocrinol Metab; 2012 Oct; 97(10):3744-50. PubMed ID: 22855334
[TBL] [Abstract][Full Text] [Related]
5. Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications.
Yamamoto M; Yamaguchi T; Yamauchi M; Kaji H; Sugimoto T
J Bone Miner Res; 2009 Apr; 24(4):702-9. PubMed ID: 19049338
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.
Yamaguchi T; Kanatani M; Yamauchi M; Kaji H; Sugishita T; Baylink DJ; Mohan S; Chihara K; Sugimoto T
Calcif Tissue Int; 2006 Jan; 78(1):18-24. PubMed ID: 16397738
[TBL] [Abstract][Full Text] [Related]
7. Incident Fracture Risk in Type 2 Diabetic Postmenopausal Women in Mainland China: Peking Vertebral Fracture Study.
Jiajue R; Qi X; Jiang Y; Wang Q; Wang W; Pei Y; Wang X; Huang W; Zheng X; Ning Z; Wang O; Li M; Xing X; Yu W; Xu L; Xia W
Calcif Tissue Int; 2019 Nov; 105(5):466-475. PubMed ID: 31511960
[TBL] [Abstract][Full Text] [Related]
8. Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes.
Yamamoto M; Yamaguchi T; Yamauchi M; Yano S; Sugimoto T
J Clin Endocrinol Metab; 2008 Mar; 93(3):1013-9. PubMed ID: 18160470
[TBL] [Abstract][Full Text] [Related]
9. Physical activity in relation to serum sclerostin, insulin-like growth factor-1, and bone turnover markers in healthy premenopausal women: a cross-sectional and a longitudinal study.
Ardawi MS; Rouzi AA; Qari MH
J Clin Endocrinol Metab; 2012 Oct; 97(10):3691-9. PubMed ID: 22865898
[TBL] [Abstract][Full Text] [Related]
10. Serum sclerostin levels associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis.
Xu XJ; Shen L; Yang YP; Lu FR; Zhu R; Shuai B; Li CG; Wu MX
Chin Med J (Engl); 2013 Jul; 126(13):2480-4. PubMed ID: 23823821
[TBL] [Abstract][Full Text] [Related]
11. Determinants of serum sclerostin in healthy pre- and postmenopausal women.
Ardawi MS; Al-Kadi HA; Rouzi AA; Qari MH
J Bone Miner Res; 2011 Dec; 26(12):2812-22. PubMed ID: 21812027
[TBL] [Abstract][Full Text] [Related]
12. Assessment using serum insulin-like growth factor-I and bone mineral density is useful for detecting prevalent vertebral fractures in patients with type 2 diabetes mellitus.
Kanazawa I; Notsu M; Miyake H; Tanaka K; Sugimoto T
Osteoporos Int; 2018 Nov; 29(11):2527-2535. PubMed ID: 30030585
[TBL] [Abstract][Full Text] [Related]
13. Relationships between sclerostin and morphometric vertebral fractures, bone mineral density, and bone microarchitecture in postmenopausal women.
Liang H; Qi W; Yu F; Jiajue R; Chi Y; Liu W; Wang O; Li M; Xing X; Yu W; Jiang Y; Xia W
Arch Osteoporos; 2023 Apr; 18(1):57. PubMed ID: 37120433
[TBL] [Abstract][Full Text] [Related]
14. Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus.
Neumann T; Hofbauer LC; Rauner M; Lodes S; Kästner B; Franke S; Kiehntopf M; Lehmann T; Müller UA; Wolf G; Hamann C; Sämann A
Clin Endocrinol (Oxf); 2014 May; 80(5):649-55. PubMed ID: 24237244
[TBL] [Abstract][Full Text] [Related]
15. High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study.
Ardawi MS; Rouzi AA; Al-Sibiani SA; Al-Senani NS; Qari MH; Mousa SA
J Bone Miner Res; 2012 Dec; 27(12):2592-602. PubMed ID: 22836717
[TBL] [Abstract][Full Text] [Related]
16. Serum insulin-like growth factor-I level is associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes mellitus.
Kanazawa I; Yamaguchi T; Yamamoto M; Yamauchi M; Yano S; Sugimoto T
Osteoporos Int; 2007 Dec; 18(12):1675-81. PubMed ID: 17632742
[TBL] [Abstract][Full Text] [Related]
17. Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes.
Yamamoto M; Yamaguchi T; Nawata K; Yamauchi M; Sugimoto T
J Clin Endocrinol Metab; 2012 Apr; 97(4):1277-84. PubMed ID: 22337915
[TBL] [Abstract][Full Text] [Related]
18. Association of osteoglycin and FAM5C with bone turnover markers, bone mineral density, and vertebral fractures in postmenopausal women with type 2 diabetes mellitus.
Tanaka KI; Kanazawa I; Kaji H; Sugimoto T
Bone; 2017 Feb; 95():5-10. PubMed ID: 27836731
[TBL] [Abstract][Full Text] [Related]
19. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
Reppe S; Noer A; Grimholt RM; Halldórsson BV; Medina-Gomez C; Gautvik VT; Olstad OK; Berg JP; Datta H; Estrada K; Hofman A; Uitterlinden AG; Rivadeneira F; Lyle R; Collas P; Gautvik KM
J Bone Miner Res; 2015 Feb; 30(2):249-56. PubMed ID: 25155887
[TBL] [Abstract][Full Text] [Related]
20. Discordance between Prevalent Vertebral Fracture and Vertebral Strength Estimated by the Finite Element Method Based on Quantitative Computed Tomography in Patients with Type 2 Diabetes Mellitus.
Kiyohara N; Yamamoto M; Sugimoto T
PLoS One; 2015; 10(12):e0144496. PubMed ID: 26642210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
